Emily Rollins - Mar 1, 2023 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Role
Director
Signature
/s/ Daniel Rodriguez, as Attorney-in-Fact for Emily Rollins
Stock symbol
DLB
Transactions as of
Mar 1, 2023
Transactions value $
-$82,040
Form type
4
Date filed
3/3/2023, 04:19 PM
Previous filing
Feb 9, 2023
Next filing
Mar 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DLB Class A Common Stock Sale -$82K -1K -13.26% $82.04 6.54K Mar 1, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held following the reported transactions include 3,296 restricted stock units, which are subject to forfeiture until they vest.

Remarks:

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.